Cargando…

A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent Mechanism

We have recently identified a chemotype of small ubiquitin-like modifier (SUMO)-specific protease (SENP) inhibitors. Prior to the discovery of their SENP inhibitory activity, these compounds were found to inhibit HIV replication, but with an unknown mechanism. In this study, we investigated the mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madu, Ikenna G., Li, Shirley, Li, Baozong, Li, Haitang, Chang, Tammy, Li, Yi-Jia, Vega, Ramir, Rossi, John, Yee, Jiing-Kuan, Zaia, John, Chen, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672295/ https://www.ncbi.nlm.nih.gov/pubmed/26643614 http://dx.doi.org/10.1038/srep17808

Ejemplares similares

Development of Hematopoietic Stem Cell Based Gene Therapy for HIV-1 Infection: Considerations for Proof of Concept Studies and Translation to Standard Medical Practice
por: DiGiusto, David L., et al.
Publicado: (2013)

HIV-1 and SUMOylation
por: Beauclair, Guillaume, et al.
Publicado: (2013)

SUMOylation in Viral Replication and Antiviral Defense
por: Fan, Yao, et al.
Publicado: (2022)

HIV-1 integrase SUMOylation and viral replication
por: Zamborlini, Alessia, et al.
Publicado: (2011)

Seven classes of antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

Long-acting antiviral agents for HIV treatment
por: Margolis, David A., et al.
Publicado: (2015)

Chapter 22. Non-HIV antiviral agents
por: Meanwell, Nicholas A., et al.
Publicado: (2003)

Dual Mechanisms of Action of Self-Delivering, Anti-HIV-1 FANA Oligonucleotides as a Potential New Approach to HIV Therapy
por: Takahashi, Mayumi, et al.
Publicado: (2019)

Drug-Class Specific Impact of Antivirals on the Reproductive Capacity of HIV
por: von Kleist, Max, et al.
Publicado: (2010)

PIAS3 modulate HIV-1 integrase SUMOylation
por: Beauclair, Guillaume, et al.
Publicado: (2011)

Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells
por: Zhou, Jiehua, et al.
Publicado: (2009)

Antiviral Therapy (Non-HIV)
por: Beigel, John H.
Publicado: (2012)

Practical Considerations in Gene Therapy for HIV Cure
por: Stan, Rodica, et al.
Publicado: (2014)

Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells
por: Modi, Hardik, et al.
Publicado: (2010)

Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles
por: Arizala, Jerlisa Ann C., et al.
Publicado: (2018)

Progress toward curing HIV infection with hematopoietic cell transplantation
por: Petz, Lawrence D, et al.
Publicado: (2015)

Engineering and optimization of the mir-106b-cluster for ectopic expression of multiplexed anti-HIV RNAs
por: Aagaard, Lars, et al.
Publicado: (2008)

Integration-defective lentiviral vector mediates efficient gene editing through homology-directed repair in human embryonic stem cells
por: Wang, Yebo, et al.
Publicado: (2017)

A Small Molecule-Controlled Cas9 Repressible System
por: Wu, Youjun, et al.
Publicado: (2020)

HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
por: Li, Shuang, et al.
Publicado: (2022)

LEDGINs, a novel class of antivirals targeting HIV integrase during integration and assembly
por: Debyser, Zeger
Publicado: (2013)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation
por: Bosque, Alberto, et al.
Publicado: (2017)

Interplay between HIV-1 infection and host microRNAs
por: Sun, Guihua, et al.
Publicado: (2012)

IRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation
por: Xia, Pengyan, et al.
Publicado: (2015)

Antimalarial chloroquine metamorphosed into antiviral agent against HIV with four modes of actions
por: Chandramohan, M, et al.
Publicado: (2012)

TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb
por: Ma, Xiancai, et al.
Publicado: (2019)

Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014)

A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro
por: Chang, Chien-Hsing, et al.
Publicado: (2012)

Using Gene Editing to Establish a Safeguard System for Pluripotent Stem-Cell-Based Therapies
por: Wu, Youjun, et al.
Publicado: (2019)

Proteomic Approaches to Dissect Host SUMOylation during Innate Antiviral Immune Responses
por: Lork, Marie, et al.
Publicado: (2021)

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine
por: Guan, Min, et al.
Publicado: (2022)

How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?
por: Saeed, Sahar, et al.
Publicado: (2016)

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
por: Zhang, Zhiqing, et al.
Publicado: (2016)

SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells
por: Martinat, Charlotte, et al.
Publicado: (2021)

γ‐Non‐Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV
por: Zhao, Chenglong, et al.
Publicado: (2020)

Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection
por: Lodi, Sara, et al.
Publicado: (2022)

Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1
por: Zhou, Jiehua, et al.
Publicado: (2018)

Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum
por: Martínez-Gualda, Belén, et al.
Publicado: (2019)

Functional In Vivo Delivery of Multiplexed Anti-HIV-1 siRNAs via a Chemically Synthesized Aptamer With a Sticky Bridge
por: Zhou, Jiehua, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bao48lj54nm112evmfod7ntmi8